Secureworks Announces Third Quarter Fiscal 2025 Results
ATLANTA, Dec. 4, 2024 /PRNewswire/ -- Secureworks® (NASDAQ: SCWX), a global leader in cybersecurity, today announced financial results for its third quarter fiscal 2025, which ended on November 1, 2024. Key Highlights Taegis™ third quarter revenue...
Instacoins Announces New Partnerships with Luxury Goods Companies for Digital Payment Acceptance
SOFIA, Bulgaria, Dec. 4, 2024 /PRNewswire/ -- Instacoins is very pleased to announce new partnerships with leading private jet service "ELBJETS", luxury yacht charter company "Luxury Catamarans", and premium timepiece specialist "Watchrr". High-end...
Gaotu Techedu Announces Third Quarter 2024 Unaudited Financial Results
BEIJING, Dec. 4, 2024 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a technology-driven education company and online large-class tutoring service provider in China, today announced its unaudited financial results for...
YES announces release of VertaCure XP G3 Systems for Advanced Packaging Applications
YES announced today that it is releasing the 3rd generation VertaCure curing systems for use in manufacturing advanced packaging solutions. FREMONT, Calif., Dec. 4, 2024 /PRNewswire/ -- Yield Engineering Systems (YES) is a leading manufacturer of...
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved immunological complete remission. In the high dose cohort, 6 out of 7 (85.7%) patients...
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery
VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieves primary endpoint, demonstrating statistical and clinical efficacy compared to vehicle in treating post-operative inflammation following cataract surgery Statistically and clinically...
TraceLink Announces Grant Recipients Driving Impact Across the Globe
BOSTON, Dec. 3, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has announced the recipients of its 2024 corporate grant program. The grants have been awarded to five...
Cellid Announces "Reference Design," its Proprietary Lightweight, AR Smart Glasses
Begins recruiting development partners for key use cases OEM partners aiming to develop their own AR glasses TOKYO, Dec. 3, 2024 /PRNewswire/ -- Cellid Inc., a developer of AR glasses displays and spatial recognition engines for next-generation...
Williams Lea bolsters leadership and growth focus with two executive committee appointments
NEW YORK, Dec. 3, 2024 /PRNewswire/ -- Global tech-enabled business support services firm Williams Lea announces the appointment of Hillary McNally as Chief Revenue Officer (CRO) and Alastair Kelly as Managing Director, Asia Pacific. These...
Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow
Researchers from Children's Hospital of Philadelphia (CHOP) seek to expand treatment access for patients MOUNTAIN VIEW, Calif., Dec. 3, 2024 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation and restoration company developing novel mRNA...